Subject
Public Health, Environmental and Occupational Health,Internal Medicine,Health Policy
Reference5 articles.
1. Pharmacotherapy and pulmonary fibrosis risk after SARS-CoV-2 infection;Zeng;Lancet Reg Health Am,2023
2. Pharmacotherapy and pulmonary fibrosis risk after SARS-CoV-2 infection: a prospective nationwide cohort study in the United States;Adegunsoye;Lancet Reg Health Am,2023
3. Treatment of fibrotic interstitial lung disease: current approaches and future directions;Johannson;Lancet,2021
4. Idiopathic pulmonary fibrosis (an update) and progressive pulmonary fibrosis in adults: an official ATS/ERS/JRS/ALAT clinical practice guideline;Raghu;Am J Respir Crit Care Med,2022
5. Validation of proposed criteria for progressive pulmonary fibrosis;Pugashetti;Am J Respir Crit Care Med,2023